FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Inspection Hits Zydus With Form-483

FDA issues Zydus Lifesciences a four-item Form FDA-483 after inspecting the firms manufacturing facility (Matoda, Gujarat, India).

latest-news-card-1
Human Drugs

Orphan Status for Ebola-like Vaccine

FDA grants Soligenix an orphan drug designation for the active ingredient in MarVax vaccine against MARV infection.

latest-news-card-1
Medical Devices

Fresenius Recalls Infusion Pump Software

Fresenius Kabi USA recalls (Class 1) its large-volume pump software of the Ivenix Infusion System due to software anomalies that have the potential to...

latest-news-card-1
Human Drugs

Sun Gets OAI Inspection at India Facility

FDA classifies a December inspection at Sun Pharmaceutical Industries Dadra, India facility as official action indicated.

latest-news-card-1
Human Drugs

Panel Backs Minimal Residual Disease Endpoint

FDAs Oncologic Drugs Advisory Committee unanimously votes (12 to 0) that the totality of data are adequate to support the use of minimal residual dise...

latest-news-card-1
Biologics

Enlivex Mixed Results of Sepsis Cell Therapy

Enlivex Therapeutics reports mixed results from its Phase 2 study of Allocetra in patients with sepsis.

latest-news-card-1
Human Drugs

PureTech Gets Fast Track on LYT-200

FDA grants PureTech Health a fast-track designation for LYT-200 in combination with anti-PD1 therapy for treating recurrent/metastatic head and neck s...

latest-news-card-1
Medical Devices

AI Software Authorized for Osteoporosis Screens

FDA grants 16 Bit Inc. a de novo marketing authorization for Rho, an AI-enabled software device aimed at improving osteoporosis screening.

latest-news-card-1
Human Drugs

EMA Committee Dismisses GLP-1 Suicidality Risk

As FDA continues to evaluate the risk of suicidal thoughts or actions in patients taking glucagon-like peptide-1 receptor agonists, the European Medic...

latest-news-card-1
Human Drugs

FDA Updates Safety Labeling for Envarsus XR

FDA approves new safety labeling for Veloxis Pharmaceuticals Envarsus XR (tacrolimus), indicated for use with other medicines to help prevent organ re...